Skip to main content

Table 1 Baseline patient and pathological characteristics modified from reference 6

From: Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Characteristic Short (%) Long (%) P-valuea
Gender
 Male 14 (61) 13 (68)  
 Female 9 (39) 6 (32) 0.75
Breslow thickness (mm)
 Mean + SD 4.9 + 6.1 1.9 + 1.6 0.016
Ulceration    
 Present 15 (65) 3 (16)  
 Absent 8 (35) 16 (84) 0.002
Number of metastatic nodes
 1 5 (22) 13 (68)  
 2-3 14 (61) 3 (16)  
  > 4 4 (17) 3 (16) 0.005
Mutation status:
 BRAF mutated    0.13
 V600E 12(52) 6 (32)  
 V600 K 1 (4)  
 BRAF wildtype 10 (43) 13 (68)  
  1. a P-values calculated using Fisher’s exact test for categorical data and Mann-Whitney test for continuous data